Skip to main content

Novel Omega-3 Fatty Acid Analogues for Treatment of Breast and Secondary Brain Cancers

Project Member(s): Rawling, T.

Start year: 2013

Summary: Stipend Activity Code: 2049010

Publications:

Rawling, T, MacDermott-Opeskin, H, Roseblade, A, Pazderka, C, Clarke, C, Bourget, K, Wu, X, Lewis, W, Noble, B, Gale, PA, O'Mara, ML, Cranfield, C & Murray, M 2020, 'Aryl urea substituted fatty acids: a new class of protonophoric mitochondrial uncoupler that utilises a synthetic anion transporter', Chemical Science, vol. 11, no. 47, pp. 12677-12685.
View/Download from: Publisher's site

Al-Zubaidi, Y, Pazderka, C, Koolaji, N, Rahman, MK, Choucair, H, Umashankar, B, Bourget, K, Chen, Y, Rawling, T & Murray, M 2019, 'Aryl-urea fatty acids that activate the p38 MAP kinase and down-regulate multiple cyclins decrease the viability of MDA-MB-231 breast cancer cells', European Journal of Pharmaceutical Sciences, vol. 129, pp. 87-98.
View/Download from: Publisher's site

Koolaji, N, Rawling, T, Bourget, K & Murray, M 2018, 'Carboxylate Analogues of Aryl‐Urea‐Substituted Fatty Acids That Target the Mitochondria in MDA‐MB‐231 Breast Cancer Cells to Promote Cell Death', ChemMedChem, vol. 13, no. 10, pp. 1036-1043.
View/Download from: Publisher's site

Murray, M, Choucair, H, Allison, S, Bourget, K, Chen, Y, Dunstan, C & Rawling, T 2017, 'O25 A novel synthetic ω-3 fatty acid epoxide analogue activates breast cancer cell killing in vitro and in vivo', Biochemical Pharmacology, vol. 139, pp. 117-117.
View/Download from: Publisher's site

Koolaji, N, Murray, M & Rawling, T 1970, 'Aryl group modification in novel anti-cancer agents based on ω-3-17,18-epoxyeicosapentaenoic acid', European Journal of Cancer, 28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, Elsevier BV, Munich, GERMANY, pp. S68-S68.
View/Download from: Publisher's site

FOR Codes: Pharmacology and Pharmaceutical Sciences